VIVEbiotech is a GMP Contract Development and Manufacturing Organization (CDMO) specialized in Lentiviral vectors. VIVE is focused on the manufacture of Research, Preclinical toxicology and GMP-grade lentiviral vectors. Sealed as Excellence Centre by European Union, VIVEbiotech is currently working with Companies based both in Europe and USA being our main interest adapting to Customer requirements considering also planning and timelines related issues. Importanly, VIVEbiotech is also developing its Lentiviral vector related technology, LENTISOMA. LENTISOMA´s technology is a non-Integrative replicative episomal lentiviral vector .
Looking for a particular VIVEbiotech employee's phone or email?
VIVEbiotech Questions
The VIVEbiotech annual revenue was $29.6 million in 2026.
Jon Alberdi Echeverria is the CEO of VIVEbiotech.
97 people are employed at VIVEbiotech.
VIVEbiotech is based in San Sebastian, Basque Country.
The NAICS codes for VIVEbiotech are [541, 54, 5417, 541713, 54171].
The SIC codes for VIVEbiotech are [873, 87].
Top VIVEbiotech Employees
-
Jon Alberdi Echeverria
CEO at VIVEbiotech
San Sebastián, PV, ES2 -
Patricio Massera
President and Board Member at VIVEbiotech
Catalonia, Spain25 -
Peter Jaehn
Vice President of Business Development at VIVEbiotech
Bergisch Gladbach, NRW, DE1 -
Diego Bochoeyer
Head of Operations- Chief Operating Officer at VIVEbiotech
Kirkland, Washington, United States22 -
Naiara Tejados
Head of Communications at VIVEbiotech
Donostia-San Sebastian, PV, ES11 -
Cristina García Muñoz
Head of downstream development department at VIVEbiotech
Donostia-San Sebastian, PV, ES2 -
Giovanna Zanella
Head of Technical Proposals and Project Manager at VIVEbiotech
Donostia-San Sebastian, PV, ES2 -
Cristina Ochando
Head of PM at VIVEbiotech
Donostia-San Sebastian, PV, ES2 -
Natalia Elizalde Urdiain
Chief Business Development Officer at VIVEbiotech
Donostia-San Sebastian, PV, ES21
Related Companies
